Short answer: Semax is a seven-amino-acid synthetic peptide — a modified fragment of the hormone ACTH — developed in Russia and registered there as an intranasal pharmaceutical. It has one of the more substantial research files in the nootropic-peptide category, and users commonly report sharper focus
[attributed user reports]. Here it lives in the NEURO blend.
Semax is one of the most searched "nootropic peptides" and one of the most loosely described. This page is the reference our Semax coverage links back to: what the molecule is, how it's thought to work, what the research explored, why format matters, and where it fits in the product line.
Where Semax came from
Semax is a synthetic heptapeptide — sequence Met-Glu-His-Phe-Pro-Gly-Pro — developed at the Institute of Molecular Genetics in Moscow in the 1980s and brought into Russian clinical use in the 1990s. Structurally it's a hybrid: the ACTH(4–7) fragment of adrenocorticotropic hormone, plus a Pro-Gly-Pro tail added to resist enzymatic breakdown.
Two identity facts deserve precision. First, it has no hormonal activity — despite its ACTH ancestry, the fragment was chosen specifically to keep central-nervous-system effects while dropping the endocrine ones; preclinical models show no cortisol rise [preclinical evidence]. Second, it is a real registered drug in Russia — listed on the national vital-medicines register as an intranasal pharmaceutical. That's a different regulatory system from the FDA's, but it means Semax's lineage is pharmaceutical development, not forum chemistry.
Know your variants: vendors sell unmodified Semax, N-acetyl Semax, and NA-Semax Amidate — chemically distinct analogs. If a label doesn't state the form, that's a red flag, not a detail.
How it's thought to work
The mechanism story researchers have pursued is a focus-and-resilience one. Preclinical work reports effects on BDNF and NGF expression — the brain's growth-and-maintenance factors — along with monoamine signaling and learning-and-memory behavior in rodents [preclinical evidence]. The shorthand: research interest in the brain's signal quality, not a stimulant-style jolt. Users who like Semax usually describe it the same way — clearer, not faster [attributed user reports].
What the research has explored
- In a rat focal-ischemia model, genome-wide analysis found Semax altered expression of immune- and vascular-system genes in ischemic brain cortex — mechanistic work probing its Russian clinical use (Medvedeva et al., 2014, PMC3987924)
[preclinical evidence]. - A 2025 study in an Alzheimer's-model mouse line found Semax reduced amyloid plaque formation in cortex and hippocampus (Radchenko et al., 2025, PMC12755871) — mouse-model findings, not human results
[preclinical evidence]. - A body of Russian clinical literature exists for neurological and cognitive applications, conducted mostly in the 1990s–2000s (e.g., Konstantinopolsky et al. 2022, PMID 36322304; Kozlovskaya et al. 2003, PMID 14969422)
[published human data — Russian-language, intranasal, unreplicated].
What users commonly report: sustained attention on long tasks, less mental fade in the afternoon, a cleaner sense of focus [attributed user reports — unquantified]. Brand-side copy describes NEURO as supporting "mental clarity and cognitive stamina" [brand claim — unverified].
Formats: intranasal legacy, strip present
Nearly everything known about Semax in humans comes from intranasal administration — like most peptides, it would be digested if swallowed, which is why the Russian pharmaceutical exists as nose drops. The strip format answers on convenience: no spray, no drip, pre-measured, pocket-friendly. Whether a peptide in Semax's size class absorbs meaningfully across the oral mucosa is the open delivery-science question we lay out on our sublingual delivery science page. Any brand quoting you a sublingual absorption percentage is quoting a number that does not exist in the literature [brand claim — unverified].
Semax is also almost never discussed alone: its sibling Selank is positioned in the literature as the calm counterpart to Semax's focus lane, and the pair drives most of the demand — which is exactly why they're blended together below.
The honest context
One bounded passage, plainly: Semax's human evidence is overwhelmingly Russian-language, single-ecosystem, decades old, and never replicated at scale internationally. That human data is for intranasal pharmaceutical forms — not strips, and not the N-acetyl analog, which has no published human data at all. Interest in the biohacker community has outrun the data by years; anyone selling certainty here is selling, not informing. If you have a real cognitive concern, the answer is a clinician. Adults 18+ only; not while pregnant or nursing.
Where Semax appears in our catalog
There is no standalone Semax product here. Semax appears in exactly one place:
- NEURO sublingual strips: 500 mcg of N-acetyl Semax alongside 500 mcg of N-acetyl Selank per strip, 20 strips per box, mint, per the Supplement Facts panel. NEURO is available at open checkout.
The strips are sold under the InstaMed brand (Salt Lake City/Draper, Utah); we sell as an authorized reseller.
The bottom line
Semax brings a real pharmaceutical pedigree, a coherent focus-mechanism story, decades of research attention, and one of the strongest user communities in the category. If the focus lane is what you're exploring, NEURO gives you N-acetyl Semax plus its natural partner Selank in one mint strip — transparent panel, 500 mcg each, 20 strips.
---
Explore this cluster
The rest of the Semax file: benefits, safety, the nasal-versus-sublingual question and the N-acetyl form.
- How to Use Semax: The Strip Makes It Simple
- Semax Side Effects: What Is — and Isn't — Actually Known
- Semax Benefits: What the Research Literature Actually Contains
- Does Sublingual Semax Work? The Unclaimed Format Question
- Sublingual vs Nasal Semax: The Format Comparison Nobody Has Written
- N-Acetyl Semax vs Semax: What's the Difference?
- Semax vs Selank: What's the Difference?
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
This content is for educational purposes only and is not medical advice. Consult a licensed healthcare provider before starting any new product. Individual results vary.